This post was contributed by Kusumika (Kushi) Mukherjee. The ultimate goal in the field of regenerative medicine is to replace lost or damaged cells. Here, I will discuss the two major processes by which an adult somatic cell is converted to a different cell type for ...
This post was contributed by Kusumika (Kushi) Mukherjee, editor of Trends in Pharmacological Sciences, a Cell Press reviews journal. Stem cells are special types of cells that can develop or “differentiate” into more specialized cells with specific functions [1]. In many ...
The field of induced pluripotent stem cells (iPSCs) has been around for 10 years. In that time, scientists have used almost all available approaches for generating iPSCs. The generation of iPSCs is relatively simple in concept: ectopically express a cocktail of stem cell ...
This post was contributed by Kusumika (Kushi) Mukherjee, a Postdoc at Massachussetts General Hospital. A little over a decade back when Yamanaka and colleagues reported that it is possible to reprogram differentiated cells into induced pluripotent stem cells (iPSCs) by the ...
Darrell Kotton is the director of the Center for Regenerative Medicine at Boston University Medical School. Darrell’s research focuses on the lungs, and, among other projects, using stem cells to develop in vitro models for lung disease. Darrell strives to promote open source ...
When our Director of Biology, Lianna Swanson, suggested that I might be able to attend the 10 Years of iPSCs Symposium earlier this year, I jumped at the chance. Here was an opportunity to see Shinya Yamanaka celebrate the tenth anniversary of his landmark Cell paper showing ...
